Advertisement

Topics

Latest "Automation Elixir Bringing Speed Efficiency Clinical Trials Development" News Stories

20:18 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Automation Elixir Bringing Speed Efficiency Clinical Trials Development" found in our extensive news archives from over 250 global news sources.

More Information about Automation Elixir Bringing Speed Efficiency Clinical Trials Development on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Automation Elixir Bringing Speed Efficiency Clinical Trials Development for you to read. Along with our medical data and news we also list Automation Elixir Bringing Speed Efficiency Clinical Trials Development Clinical Trials, which are updated daily. BioPortfolio also has a large database of Automation Elixir Bringing Speed Efficiency Clinical Trials Development Companies for you to search.

Showing "Automation Elixir Bringing Speed Efficiency Clinical Trials Development" News Articles 1–25 of 30,000+

Tuesday 26th March 2019

Shineco, Inc. Receives Regional Government Merchants Invitation for its Industrial Hemp Business Line

BEIJING, March 26, 2019 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and other health and well-being focused plant-based products in China, announced today that the Company received a merchant's invitation (the "Invitation"...


Baxter Highlights Advancements in Clinical Nutrition at ASPEN Conference

Reinforces the company’s efforts to innovate nutrition formulations and delivery mechanisms to meet the needs of patients Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S. later this year ...

Remifentanil Hydrochloride Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Remifentanil Hydrochloride report provides an independent information about the Remifentanil Hydrochloride industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent...


Curadite, Inc. Selected for National Epilepsy Foundation Shark Tank Competition

Curadite, Inc. will compete for awards totaling up to $200,000 in the Epilepsy Foundation Shark Tank Finals, which take place in Aventura, FL on May 23, 2019 at the

New Mexico to Become First State to Institute Life-Saving Legislation

SB 143 To Be Signed by Governor Lujan-Grisham Tomorrow, March 27, 2019, SB 143 will be signed by New Mexico Governor Michelle Lujan-Grisham. This legislation will make New Mexico the first state in the nation to ensure that fire and smoke dampers and smoke control systems are properly tested and inspected in accordance with National Fire Protection Ass...

PlayCore releases newest evidence-based publication, the Science of Play, featuring work by Dr. Stuart Brown

Treatise of articles helps expand knowledge of play as an important element of life for people of all ages CHATTANOOGA, Tenn. (PRWEB) March 26, 2019 PlayCore releases newest evidence-based publication, the Science of Play, featuring work by Dr. Stuart Brown Renowned play expert Dr Stuart Brown is committed to bringing the unrealized knowledge, practices, and benefits of play into public life. Thr...

Triplex Meets Primary Endpoint in Phase 2 Clinical Trial, Reduces Rate of Cytomegalovirus (CMV) Complications in Transplant Recipients by 50 Percent

First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem cell transplant recipients City of Hope, a world-renowned cancer research and treatment center, announced today that Triplex has met its primary endpoint (reduction of CMV events) in a

Pulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual Conference

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX™ System, today announced that key findings from its clinical programs using Nano-Pulse Stimulation™ (NPS™) technology will be presented at the American Society for Laser Medicine and Surgery’s (ASLMS) Annual Conference being held March 27-31, ...

Stanford Health Care Joins Sutter Health | Aetna Network

Joint venture expands its provider network for Northern California employers and members Sutter Health | Aetna today announced that Stanford Health Care has joined the Northern California joint venture’s network of health care providers. The addition of another nationally recognized health care system marks the latest in the organization’s efforts ...

Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction

Settlement will establish national center for addiction studies and treatment in Tulsa; Sackler family announces voluntary contribution to support national center Purdue Pharma L.P. today announced that it has entered into a landmark agreement with the state of Oklahoma that will establish a National Center for Addiction Studies and Treatment...

Your NEJM Group Today: Hand & Wrist Exam Video / Spinal Manipulative Therapy & Low Back Pain / Nephrology & Geriatrics Opportunities

Take a peek at today's top picks from NEJM Group: NEJM Primary Care/Hospitalist Page: Videos in Clinical Medicine: This video describes the anatomy of...

Publisher’s Spotlight: 2019 CARE Awards Finalists

Informa Pharma Intelligence is delighted to announce the shortlist for the 2019 Clinical and Research Excellence Awards, to be presented...    

Roche quietly discontinues Ignyta cancer therapy RXDX-105

Roche’s RXDX-105, which was being developed by Ignyta, has had its development discontinued, according to an industry source. The move...Read More... The post Roche quietly discontinues Ignyta cancer therapy RXDX-105 appeared first on Pharmaceutical Technology.

Apple Heart Study Ate Up Day 1 of ACC

As work schedules demand shorter conferences, ACC opened with one late-breaking clinical trial session featuring a single study, leaving 20 late-breakers for the final 2 days. theheart.org on Medscape

Press Ganey Releases State-of-the-Art Digital Platform to Advance Health Care Workforce Transformation

Enhanced capabilities deliver industry’s only integrated view across engagement, resilience, and safety culture Press Ganey today announced the release of its advanced Workforce and Engagement Solution, enabling health care systems to measure, identify, and act on improvement opportunities at unprecedented levels. The platform delive...

STAT Plus: The new analysis found nearly one-third of hundreds of clinical trials have not been disclosed over the past two years by several of the most prestigious research universities in the U.S., despite federal law requirements. https://buff.ly/2UgxJ

STAT Plus: The new analysis found nearly one-third of hundreds of clinical trials have not been disclosed over the past two years by several of the most prestigious research universities in the U.S., despite federal law requirements. https://buff.ly/2UgxJt2 

Delaware Innovation Space Receives $3+ Million Investment to Support Its Mission of Advancing Science-Based Start-Ups

National Development Council, Discover Bank, and Delaware Innovation Space Partner on Creating Jobs and Broadening Delaware’s Economic Base Delaware Innovation Space announced today that it has received $3 million in funding from National Development Council (NDC), through a start-up innovation loan program established with Discover Bank, along with ...

The Proposed Noorda College of Osteopathic Medicine Board of Trustees Holds Inaugural Meeting

Inaugural Trustees and officers instated The Board of Trustees for the proposed Noorda College of Osteopathic Medicine met for the first time Monday and instated Trustee members and approved bylaws and policies. Francis Gibson, MSW, MBA, Utah House Representative and House Majority Leader, and CEO of Orem Community Hospital was appointed Chair. ...

Stretcher Chairs Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Stretcher Chairs report provides an independent information about the Stretcher Chairs industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The rep...

Smartphone App May Boost Social Skills in Kids With Autism

TUESDAY, March 26, 2019 -- A smartphone application that works with Google Glass might help kids with autism build their social skills, a small clinical trial suggests. Researchers found that over six weeks, kids who used the app at home with their...

NanoSurface Biomedical Launches New Drug Screening Platform with Structurally Matured Human Heart Tissues Derived from Stem Cells

NanoSurface Biomedical, a leading provider of biomimetic cell-based assay products and services, announced today the launch of the NanoSurface Car(ina)™ platform for highly predictive pre-clinical drug screening, using structurally matured human induced pluripotent stem cell (iPSC) derived heart tissues. This innovative human stem cell-based technology e...

UnitedHealthcare’s Investments in Affordable Housing to Help People Achieve Better Health Surpass $400 Million

Investments have helped build 80 communities in 18 states resulting in more than 4,500 new, affordable homes with on-site support services to help people live healthier lives UnitedHealthcare announced it has surpassed $400 million in investments in new affordable housing as part of the company’s ongoing efforts to remove social b...

Perspectum Diagnostics Named Fastest Growing UK-based Life Science Company

Perspectum has been named by Beauhurst as the fastest growing Life Science Company in the UK. Beauhurst, specialists in assessing start-ups and fast-growing British companies, released the findings earlier this month. Perspectum’s turnover growth was measured against 23,000 other companies, with results setting it in first place. This rapid grow...

Javara rides with Uber to reduce trial participation barriers

Javara is offering transportation for clinical trial participants via Uber Health, which enables patients to schedule prepaid rides up to 30 days in advance of site visits.

Promedior Receives Breakthrough Therapy Designation from FDA for PRM-151 in Idiopathic Pulmonary Fibrosis

LEXINGTON, Mass., March 26, 2019 /PRNewswire/ — Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that PRM-151, a novel investigational anti-fibrotic immunomodulator, has been granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for Idiopathic Pulmonary Fibrosis (IPF).&...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks